Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Commercial Insight: Asthma & COPD' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Stakeholder Insight: COPD in Emerging Markets (Brazil, India, China, US) Key differences in treatment despite standardized guidelines |
Dec 2010 | £9,615 | 100% |
| GPCRs in Drug Discovery Efforts to De-Orphanize Novel Gpcr Targets Are Increasing |
Nov 2011 | £2,215 | 85% |
| New Drug Futures 2009 | Jan 2012 | £1,995 | 78% |
| Personalized Medicine 2010 Assessing the Opportunities and Challenges in Commercializing Companion |
May 2010 | £1,580 | 70% |
| Outlook for RNAi, 2007 siRNA and miRNA in biology, diagnostics and therapeutics |
Jun 2007 | £1,820 | 60% |
| Top 10 Drug Delivery Technologies Market | Feb 2011 | £2,940 | 52% |
- Results 1 - 6 of 6
-
-
- 1
-
-
